|
|
|
|
LEADER |
03598nam a22004455i 4500 |
001 |
978-1-4419-5635-4 |
003 |
DE-He213 |
005 |
20150519174840.0 |
007 |
cr nn 008mamaa |
008 |
100825s2010 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781441956354
|9 978-1-4419-5635-4
|
024 |
7 |
|
|a 10.1007/978-1-4419-5635-4
|2 doi
|
040 |
|
|
|d GrThAP
|
050 |
|
4 |
|a RE1-994
|
072 |
|
7 |
|a MJQ
|2 bicssc
|
072 |
|
7 |
|a MED063000
|2 bisacsh
|
082 |
0 |
4 |
|a 617.7
|2 23
|
245 |
1 |
0 |
|a Inflammation and Retinal Disease: Complement Biology and Pathology
|h [electronic resource] /
|c edited by John D. Lambris, Anthony P. Adamis.
|
264 |
|
1 |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2010.
|
300 |
|
|
|a XIV, 170 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|x 0065-2598 ;
|v 703
|
505 |
0 |
|
|a The Case for Complement and Inflammation in AMD: Open Questions -- The Role of Complement in AMD -- Multiple Interactions of Complement Factor H with Its Ligands in Solution: A Progress Report -- Genetic Control of Complement Activation in Humans and Age Related Macular Degeneration -- Bisretinoids of RPE Lipofuscin: Trigger for Complement Activation in Age-Related Macular Degeneration -- The Role of the Classical Complement Cascade in Synapse Loss During Development and Glaucoma -- A Role for Complement in Glaucoma? -- The ATP-Binding Cassette Transporter ABCA4: Structural and Functional Properties and Role in Retinal Disease -- Suppression of Drusen Formation by Compstatin, a Peptide Inhibitor of Complement C3 activation, on Cynomolgus Monkey with Early-Onset Macular Degeneration -- A Targeted Inhibitor of the Complement Alternative Pathway Reduces RPE Injury and Angiogenesis in Models of Age-Related Macular Degeneration -- Complement Depletion with Humanized Cobra Venom Factor in a Mouse Model of Age-Related Macular Degeneration.
|
520 |
|
|
|a Numerous studies have pointed to the key role of complement in the pathogenesis of retinal disease, particularly age-related macular degeneration (AMD). Reports about new gene associations and links to other physiological pathways are emerging almost on a weekly base. Several promising clinical candidates covering a wide area of potential treatment applications are in the pipelines of both industrial and academic groups. This indicates an increasing interest in complement as a therapeutic target. In view of these exciting discoveries, scientists from around the world convened at the 1st Aegean Conferences Conference on Inflammation and Retinal Disease: Complement Biology and Pathology (June 10-17, 2007) in Crete, Greece, to discuss recent advances in this rapidly-evolving field. This volume represents a collection of topics on the functions of complement in eye diseases, pathophysiology, protein structures, and complement therapeutics discussed during the conference.
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Ophthalmology.
|
650 |
1 |
4 |
|a Medicine & Public Health.
|
650 |
2 |
4 |
|a Ophthalmology.
|
700 |
1 |
|
|a Lambris, John D.
|e editor.
|
700 |
1 |
|
|a Adamis, Anthony P.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9781441956347
|
830 |
|
0 |
|a Advances in Experimental Medicine and Biology,
|x 0065-2598 ;
|v 703
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-1-4419-5635-4
|z Full Text via HEAL-Link
|
912 |
|
|
|a ZDB-2-SBL
|
950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|